The primary endpoint was the composite of CV mortality , re-hospitalization , or , extended initial hospital stay , due to diagnosis of HF , sustained ventricular tachycardia or fibrillation , ejection fraction 40 % , or elevated BNP/NT-proBNP at 1 month or more after randomization .